These results suggest that canonical Wnt signaling activation is compromised beginning in the early stage of AD-like pathology in the 3xTg-AD model, starting with the upregulation of Dkk-1 and, later, with a decrease in the expression of the Wnt7a agonist and the LRP6 coreceptor. This evidence concerns the gene WNT7A and Alzheimer disease.